UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Avoiding over-cancellation and unrealistic allocations helps maintain a sustainable Zero Based Budgeting plan, ensuring it works long term.
18,749 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
February was brutal for some software names. This piece breaks down why monday.com stock lost february, what that sig...
With rates cutting into CD income, retirees are looking at corporate bond ETFs for steadier payouts. This story expla...
When a major streaming giant ends a brand partnership, the ripple effects reach creators, investors, and households. ...
Hims Hers Health shares jumped after news of a Novo Nordisk collaboration. This guide breaks down what the deal could...
Intuit has faced a sharp share-price pullback this year. This guide breaks down the why, the risk factors, and what i...
IREN is reshaping its business from crypto mining to AI data centers. This analysis dives into how the move affects i...
As volatility persists in 2026, investors are turning to best stocks under $20 for value, dividend income, and potent...
What if Robinhood launched a premium platinum card? This article explores the strategic move, potential perks, and ho...
Regulators revived a stalled pipeline, prompting questions for investors in Sable Offshore. This guide breaks down wh...
When a mining stock slumps, it usually signals a mix of precious metal prices, costs, and market sentiment. This piec...
A new humanoid robot from a major player has people talking. This article breaks down what a rival with a familiar lo...